sunvozertinib
dizal pharmaceuticals
['sunvozertinib', 'dzd9008']
#asco23 abs#9002 results of dzd9008 - sunvozertinib in pts w/ exon 20 #egfr mutation median 2l of prior tx orr ~61%, n=100 orr 48.5% in baseline brain mets dor 11 mo 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl